Albendazole: a new therapeutic regimen in cutaneous larva migrans

Background Various therapeutic modalities have been used to treat cutaneous larva migrans, including physical treatments (cryotherapy), topical drugs (tiabendazole), and systemic drugs (tiabendazole, albendazole, and ivermectin). Physical treatments are often ineffective and not devoid of side‐effects. Topical tiabendazole is difficult to find in many countries; it is effective orally but frequently causes side‐effects. Ivermectin has been used in a small number of patients.

[1]  P. Pauluzzi,et al.  Larva migrans: Report of three cases. Therapeutic advice , 1996 .

[2]  Antonio WONG‐WALDAMEZ,et al.  BULLOUS LARVA MIGRANS ACCOMPANIED BY LOEFFLER'S SYNDROME , 1995, International journal of dermatology.

[3]  G. Galbiati,et al.  LARVA MIGRANS IN ITALY , 1995, International journal of dermatology.

[4]  A. D. Carlo,et al.  DUE CASI DI CREEPING DISEASE: RISULTATI DEL TRATTAMENTO CON ALBENDAZOLO , 1995 .

[5]  S. Jones Cutaneous larva migrans—‘recurrens’ , 1994, The British journal of dermatology.

[6]  G. Wiedermann,et al.  Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  E. Caumes,et al.  A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. , 1993, The American journal of tropical medicine and hygiene.

[8]  H. Davies,et al.  Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. , 1993, Archives of dermatology.

[9]  S. Sanguigni,et al.  Albendazole in the therapy of cutaneous larva migrans. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  N. Reynolds,et al.  Oral albendazole for the treatment of cutaneous larva migrans , 1990, The British journal of dermatology.

[11]  H. C. Williams,et al.  Creeping eruption stopped in its tracks by albendazole , 1989, Clinical and experimental dermatology.